The future of medicine is here. Part 3: More on the biologics in asthma
Dr Parameswaran Nair, professor of medicine in the Division of Respirology at McMaster University, talks about clinical trials and costs of using biologics in asthma.
Dr Parameswaran Nair, professor of medicine in the Division of Respirology at McMaster University, talks about clinical trials and costs of using biologics in asthma.
Dr Parameswaran Nair, professor of medicine in the Division of Respirology at McMaster University, explains the mechanisms of action of biologics in asthma.
Dr Parameswaran Nair, professor of medicine in the Division of Respirology at McMaster University, talks about the future advances in medicine and use of benralizumab in asthma.
Dr Holger Schünemann, chair of the Department of Health, Evidence and Impact at McMaster University, discusses the WHO guideline update on multidrug-resistant tuberculosis.
Dr Gordon Guyatt, Distinguished Professor at McMaster University Department of Health Research Methods, Evidence, and Impact and one of the founders of evidence-based medicine, discusses new Canadian guidelines on opioid use in chronic noncancer pain.
Dr Holger Schünemann explains in what ways new European breast cancer screening guidelines differ from previously issued recommendations and talks about their implementation.
Dr Holger Schünemann, chair of the Department of Health, Evidence and Impact at McMaster University, on reasons and methods for developing European breast cancer screening guidelines.
In the final episode on colorectal cancer screening, Dr David Morgan discusses FIT tests and the future of screening.
Dr Paul O’Byrne, Dean and Vice-President of Faculty of Health Sciences at McMaster University, discusses fish oil supplementation in pregnancy and in patients with asthma.
In the second McMaster Perspective episode on colorectal cancer screening, Dr David Morgan compares acceptability and efficacy of different screening strategies.